Global Human Growth Hormone Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Human Growth Hormone market size was valued at US$ 4899 million in 2024 and is forecast to a readjusted size of USD 6142 million by 2031 with a CAGR of 3.3% during review period.
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono and F. Hoffmann-La Roche, account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry.
North America occupied 42% of the production market. It is followed by Europe and China, which respectively have around 27% and 16% of the global total industry. Other countries have a small amount of production. Geographically, North America was the largest consumption market in the world, which took about 44.59% of the global consumption volume.
This report is a detailed and comprehensive analysis for global Human Growth Hormone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Growth Hormone market size and forecasts, in consumption value ($ Million), sales quantity (Million IU), and average selling prices (USD/IU), 2020-2031
Global Human Growth Hormone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Million IU), and average selling prices (USD/IU), 2020-2031
Global Human Growth Hormone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Million IU), and average selling prices (USD/IU), 2020-2031
Global Human Growth Hormone market shares of main players, shipments in revenue ($ Million), sales quantity (Million IU), and ASP (USD/IU), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Growth Hormone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Growth Hormone market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human Growth Hormone market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Powder
Solvent
Market segment by Application
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others
Major players covered
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Growth Hormone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Growth Hormone, with price, sales quantity, revenue, and global market share of Human Growth Hormone from 2020 to 2025.
Chapter 3, the Human Growth Hormone competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Growth Hormone breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human Growth Hormone market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Growth Hormone.
Chapter 14 and 15, to describe Human Growth Hormone sales channel, distributors, customers, research findings and conclusion.
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono and F. Hoffmann-La Roche, account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry.
North America occupied 42% of the production market. It is followed by Europe and China, which respectively have around 27% and 16% of the global total industry. Other countries have a small amount of production. Geographically, North America was the largest consumption market in the world, which took about 44.59% of the global consumption volume.
This report is a detailed and comprehensive analysis for global Human Growth Hormone market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Growth Hormone market size and forecasts, in consumption value ($ Million), sales quantity (Million IU), and average selling prices (USD/IU), 2020-2031
Global Human Growth Hormone market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Million IU), and average selling prices (USD/IU), 2020-2031
Global Human Growth Hormone market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Million IU), and average selling prices (USD/IU), 2020-2031
Global Human Growth Hormone market shares of main players, shipments in revenue ($ Million), sales quantity (Million IU), and ASP (USD/IU), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Growth Hormone
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Growth Hormone market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human Growth Hormone market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Powder
Solvent
Market segment by Application
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others
Major players covered
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F. Hoffmann-La Roche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Growth Hormone product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Growth Hormone, with price, sales quantity, revenue, and global market share of Human Growth Hormone from 2020 to 2025.
Chapter 3, the Human Growth Hormone competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Growth Hormone breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human Growth Hormone market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Growth Hormone.
Chapter 14 and 15, to describe Human Growth Hormone sales channel, distributors, customers, research findings and conclusion.
Table of Contents
125 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Human Growth Hormone by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
- 10 South America
- 11 Middle East & Africa
- 12 Market Dynamics
- 13 Raw Material and Industry Chain
- 14 Shipments by Distribution Channel
- 15 Research Findings and Conclusion
- 16 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
